These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8326132)

  • 1. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.
    Parmely MJ; Zhou WW; Edwards CK; Borcherding DR; Silverstein R; Morrison DC
    J Immunol; 1993 Jul; 151(1):389-96. PubMed ID: 8326132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues.
    Bradshaw M; Rutherford MS; Hoeper BJ; McWhinney CD; Borcherding DR; Schook LB; Edwards CK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1506-18. PubMed ID: 7791126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbocyclic nucleosides as inhibitors of human tumor necrosis factor-alpha production: effects of the stereoisomers of (3-hydroxycyclopentyl)adenines.
    Borcherding DR; Peet NP; Munson HR; Zhang H; Hoffman PF; Bowlin TL; Edwards CK
    J Med Chem; 1996 Jun; 39(13):2615-20. PubMed ID: 8691460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.
    Haskó G; Szabó C; Németh ZH; Kvetan V; Pastores SM; Vizi ES
    J Immunol; 1996 Nov; 157(10):4634-40. PubMed ID: 8906843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline.
    Al-Humidan A; Edwards CK; Al-Sofi A; Dzimiri M; Al-Sedairy ST; Khabar KS
    Cell Immunol; 1998 Aug; 188(1):12-8. PubMed ID: 9743553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T; Hisadome M; Komatsu H
    J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.
    Ning Q; Brown D; Parodo J; Cattral M; Gorczynski R; Cole E; Fung L; Ding JW; Liu MF; Rotstein O; Phillips MJ; Levy G
    J Immunol; 1998 Apr; 160(7):3487-93. PubMed ID: 9531310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of iron status on endotoxin-induced mortality, phagocytosis and interleukin-1 alpha and tumor necrosis factor-alpha production.
    Omara FO; Blakley BR; Huang HS
    Vet Hum Toxicol; 1994 Oct; 36(5):423-8. PubMed ID: 7839567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro.
    Haskó G; Szabó C; Németh ZH; Lendvai B; Vizi ES
    Br J Pharmacol; 1998 Jul; 124(6):1099-106. PubMed ID: 9720779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma enhances tumor necrosis factor-alpha production by inhibiting early phase interleukin-10 transcription.
    Shakhov AN; Woerly G; Car BD; Ryffel B
    Eur Cytokine Netw; 1996 Dec; 7(4):741-50. PubMed ID: 9010676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha.
    Barrios-Rodiles M; Tiraloche G; Chadee K
    J Immunol; 1999 Jul; 163(2):963-9. PubMed ID: 10395693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines.
    Ryzhov S; Zaynagetdinov R; Goldstein AE; Novitskiy SV; Blackburn MR; Biaggioni I; Feoktistov I
    J Pharmacol Exp Ther; 2008 Feb; 324(2):694-700. PubMed ID: 17965229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
    Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E
    Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.